Markets News

Fiat Misses Q4 EPS Estimates, Faces EPA Investigation

  Despite posting an increase in the fiscal 2016 fourth-quarter revenue, compared with last year, the stock of automaker Fiat Chrysler Automobiles N.V. (NYSE: FCAU) has so far appreciated only by about 5% to $11.38. One of the reasons for

Read More

Rio Tinto Swings to Profit in FY16, Beats Earnings View

  In the second week of February, mining giant Rio Tinto Plc (NYSE: RIO) reported a decline in the fiscal 2016 revenue, compared with last year. However, the stock hit a 12-month high of $47.11. The main reason for the

Read More

Novartis Misses Q4 Rev. View, Issues Flat FY17 Outlook

  Since reporting fiscal 2016 fourth-quarter earnings that beat analysts’ estimates, the stock of Pharmaceutical company Novartis Ag (NYSE: NVS) has risen by 5% to $77.20 (as of Monday). Ironically, the company’s Q4 revenue was below analysts’ expectations. Analysts attribute

Read More

Teva Beats 4Q16 Estimates, Reaffirms FY17 EPS View

  World’s largest generic drug manufacturer Teva Pharmaceutical Industries Ltd (NYSE: TEVA) had missed its own earning guidance in the second and third-quarter of fiscal 2016. This had kept investors on edge during the latest quarter. Fortunately, on Monday, the

Read More

BP Misses 4Q16 Underlying Replacement Profit Estimates

  Last week, the “supermajor” oil company BP Plc (NYSE: BP) reported a swing to profit in the fiscal 2016 fourth-quarter, compared with a net loss in the similar quarter of fiscal 2015. The company also reported a y-o-y increase

Read More

Coca-Cola Beats 4Q16 View, Issues Soft FY17 Rev Outlook

  Despite beating Zacks earnings and revenue estimates for fiscal 2016 fourth-quarter, the stock of food and beverage company Coca-Cola Company (NYSE: KO) has lost about 5% in the past three trading sessions to close at $40.62 on Monday. While

Read More

Wynn Resorts Remain Weak on Missing Q4 EPS View

  The stock of casino operator Wynn Resorts (NASDAQ: WYNN) recorded a 12-month high of $104.39 on January 30th. The upswing was mainly due to the announcement of fiscal 2016 fourth-quarter revenue that beat analysts’ estimates. However, the company failed

Read More

Pfizer Misses Q4 EPS View, Issues Upbeat FY17 Outlook

  The largest US drug manufacturer Pfizer Inc (NYSE: PFE) reported a swing to profit in the fiscal 2016 fourth-quarter, compared with a net loss in the similar quarter of fiscal 2015. However, the non-GAAP earnings declined 11% y-o-y. The

Read More

Citigroup Q4 EPS Tops View, Fixed Income Rev up 36% y-o-y

  Following the announcement of fiscal 2016 fourth-quarter results on January 18th, the stock of Citigroup Inc (NYSE: C) fell 5% to hit a low of $55.21. However, in the past three trading sessions, the stock regained the lost ground

Read More

Multi-Year High Iron Ore Price Keeps Aussie in Uptrend

  Last week, strategists at Morgan Stanley and Societe Generale suggested going short in the AUDUSD pair. Their argument was primarily based on the fact that the Aussie is fast losing its attraction as a carry trade currency. Furthermore, analysts

Read More